Css LLC Amicus Therapeutics, Inc. Call Options Transaction History

Css LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2018 Aug 14, 2018	SELL	$13.13 - $17.09 $262,600 - $341,800	-20,000 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$13.76 - $17.12 $275,200 - $342,400	-20,000 Reduced 50.0%	20,000 $301,000
Q4 2017 Feb 14, 2018	BUY	$12.51 - $16.24 $362,790 - $470,959	29,000 Added 263.64%	40,000 $576,000
Q3 2017 Nov 14, 2017	BUY	$11.74 - $15.78 $129,140 - $173,580	11,000	11,000 $166,000

312

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.